Comparison of expected health impacts for major cancers: Integration of incidence rate and loss of quality-adjusted life expectancy

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Purpose: The study aims to quantify the expected impacts of different cancers through multiplying the incidence rate by loss-of-QALE (quality-adjusted life expectancy), with QALY (quality-adjusted life year) as the common unit, to aid prevention policy decisions. Methods: 464,722 patients with pathologically verified cancer registered in the Taiwan Cancer Registry during 1998-2009 were used to estimate lifetime survival through Kaplan-Meier estimation combined with a semi-parametric method. A convenience sample for measuring the utility value with EQ-5D was conducted with 11,453 cancer patients, with the results then multiplied by the survival functions to estimate QALE. The loss-of-QALE was calculated by subtracting the QALE of each cancer cohort from the life expectancy of the corresponding age- and gender-matched reference population. The cumulative incidence rates from age 20 to 79 (CIR20-79) were calculated to estimate the lifetime risk of cancer for each organ-system. Results: Liver and lung cancer were found the highest expected lifetime health impacts in males and females, or expected lifetime losses of 0.97 and 0.41 QALYs that could be averted, respectively. While the priority changes for prevention based on expected health impacts were slightly different for females based on standardized mortality rates, those of males involve a broader spectrum, including oral, colorectal, esophageal and stomach cancer. Conclusion: The integration of incidence rate with loss-of-QALE could be used to represent the expected losses that could be averted by prevention, which may be useful in prioritizing strategies for cancer control.

Original languageEnglish
Pages (from-to)126-132
Number of pages7
JournalCancer Epidemiology
Volume39
Issue number1
DOIs
Publication statusPublished - 2015 Feb 1

Fingerprint

Life Expectancy
Quality of Life
Incidence
Health
Neoplasms
Quality-Adjusted Life Years
Survival
Mouth Neoplasms
Liver Neoplasms
Esophageal Neoplasms
Taiwan
Stomach Neoplasms
Registries
Colorectal Neoplasms
Lung Neoplasms
Mortality
Population

All Science Journal Classification (ASJC) codes

  • Epidemiology
  • Oncology
  • Cancer Research

Cite this

@article{d932901982f8449cb29aaf0544ae264e,
title = "Comparison of expected health impacts for major cancers: Integration of incidence rate and loss of quality-adjusted life expectancy",
abstract = "Purpose: The study aims to quantify the expected impacts of different cancers through multiplying the incidence rate by loss-of-QALE (quality-adjusted life expectancy), with QALY (quality-adjusted life year) as the common unit, to aid prevention policy decisions. Methods: 464,722 patients with pathologically verified cancer registered in the Taiwan Cancer Registry during 1998-2009 were used to estimate lifetime survival through Kaplan-Meier estimation combined with a semi-parametric method. A convenience sample for measuring the utility value with EQ-5D was conducted with 11,453 cancer patients, with the results then multiplied by the survival functions to estimate QALE. The loss-of-QALE was calculated by subtracting the QALE of each cancer cohort from the life expectancy of the corresponding age- and gender-matched reference population. The cumulative incidence rates from age 20 to 79 (CIR20-79) were calculated to estimate the lifetime risk of cancer for each organ-system. Results: Liver and lung cancer were found the highest expected lifetime health impacts in males and females, or expected lifetime losses of 0.97 and 0.41 QALYs that could be averted, respectively. While the priority changes for prevention based on expected health impacts were slightly different for females based on standardized mortality rates, those of males involve a broader spectrum, including oral, colorectal, esophageal and stomach cancer. Conclusion: The integration of incidence rate with loss-of-QALE could be used to represent the expected losses that could be averted by prevention, which may be useful in prioritizing strategies for cancer control.",
author = "Hung, {Mei Chuan} and Wu-Wei Lai and Chen, {Helen H.W} and Wu-Chou Su and Jung-Der Wang",
year = "2015",
month = "2",
day = "1",
doi = "10.1016/j.canep.2014.12.004",
language = "English",
volume = "39",
pages = "126--132",
journal = "Cancer Epidemiology",
issn = "1877-7821",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - Comparison of expected health impacts for major cancers

T2 - Integration of incidence rate and loss of quality-adjusted life expectancy

AU - Hung, Mei Chuan

AU - Lai, Wu-Wei

AU - Chen, Helen H.W

AU - Su, Wu-Chou

AU - Wang, Jung-Der

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Purpose: The study aims to quantify the expected impacts of different cancers through multiplying the incidence rate by loss-of-QALE (quality-adjusted life expectancy), with QALY (quality-adjusted life year) as the common unit, to aid prevention policy decisions. Methods: 464,722 patients with pathologically verified cancer registered in the Taiwan Cancer Registry during 1998-2009 were used to estimate lifetime survival through Kaplan-Meier estimation combined with a semi-parametric method. A convenience sample for measuring the utility value with EQ-5D was conducted with 11,453 cancer patients, with the results then multiplied by the survival functions to estimate QALE. The loss-of-QALE was calculated by subtracting the QALE of each cancer cohort from the life expectancy of the corresponding age- and gender-matched reference population. The cumulative incidence rates from age 20 to 79 (CIR20-79) were calculated to estimate the lifetime risk of cancer for each organ-system. Results: Liver and lung cancer were found the highest expected lifetime health impacts in males and females, or expected lifetime losses of 0.97 and 0.41 QALYs that could be averted, respectively. While the priority changes for prevention based on expected health impacts were slightly different for females based on standardized mortality rates, those of males involve a broader spectrum, including oral, colorectal, esophageal and stomach cancer. Conclusion: The integration of incidence rate with loss-of-QALE could be used to represent the expected losses that could be averted by prevention, which may be useful in prioritizing strategies for cancer control.

AB - Purpose: The study aims to quantify the expected impacts of different cancers through multiplying the incidence rate by loss-of-QALE (quality-adjusted life expectancy), with QALY (quality-adjusted life year) as the common unit, to aid prevention policy decisions. Methods: 464,722 patients with pathologically verified cancer registered in the Taiwan Cancer Registry during 1998-2009 were used to estimate lifetime survival through Kaplan-Meier estimation combined with a semi-parametric method. A convenience sample for measuring the utility value with EQ-5D was conducted with 11,453 cancer patients, with the results then multiplied by the survival functions to estimate QALE. The loss-of-QALE was calculated by subtracting the QALE of each cancer cohort from the life expectancy of the corresponding age- and gender-matched reference population. The cumulative incidence rates from age 20 to 79 (CIR20-79) were calculated to estimate the lifetime risk of cancer for each organ-system. Results: Liver and lung cancer were found the highest expected lifetime health impacts in males and females, or expected lifetime losses of 0.97 and 0.41 QALYs that could be averted, respectively. While the priority changes for prevention based on expected health impacts were slightly different for females based on standardized mortality rates, those of males involve a broader spectrum, including oral, colorectal, esophageal and stomach cancer. Conclusion: The integration of incidence rate with loss-of-QALE could be used to represent the expected losses that could be averted by prevention, which may be useful in prioritizing strategies for cancer control.

UR - http://www.scopus.com/inward/record.url?scp=84924954095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924954095&partnerID=8YFLogxK

U2 - 10.1016/j.canep.2014.12.004

DO - 10.1016/j.canep.2014.12.004

M3 - Article

C2 - 25553846

AN - SCOPUS:84924954095

VL - 39

SP - 126

EP - 132

JO - Cancer Epidemiology

JF - Cancer Epidemiology

SN - 1877-7821

IS - 1

ER -